Q1 2021 OpGen Inc Earnings Call Transcript
Good morning, and thank you for joining us today. I would now like to hand the call over to Megan Paul of Investor Relations. Megan, the floor is yours.
Welcome to the OpGen First Quarter 2021 Earnings Call and Business Update. At this time, all participants are in a listen-only mode. Following management's prepared remarks, there will be a Q&A session. As a reminder, this conference call is being recorded today, May 13, 2021.
Before we begin, I would like to caution you that comments made during this conference call by management may contain forward-looking statements regarding the operations of and future results of OpGen, including its subsidiaries Curetis and Ares Genetics. We encourage you to review OpGen's filings with the Securities and Exchange Commission, including without limitation the company's most recent Form 10-K and Form 10-Q for the first quarter of 2021, that may be filed with the SEC -- that will be filed with the SEC, which will identify specific factors that may cause actual
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |